S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:CRLBF

Cresco Labs (CRLBF) Stock Price, News & Analysis

$2.07
-0.16 (-7.17%)
(As of 03/28/2024 ET)
Today's Range
$2.05
$2.25
50-Day Range
$1.52
$2.57
52-Week Range
$1.00
$2.77
Volume
948,078 shs
Average Volume
954,534 shs
Market Capitalization
$715.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.33

Cresco Labs MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
882.3% Upside
$20.33 Price Target
Short Interest
Healthy
0.51% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.17mentions of Cresco Labs in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.15 out of 5 stars

CRLBF stock logo

About Cresco Labs Stock (OTCMKTS:CRLBF)

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

CRLBF Stock Price History

CRLBF Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Reviewing Cresco Labs (OTCMKTS:CRLBF) and Akanda (NASDAQ:AKAN)
Crypto Market Preps For Trillions Worth of Inflows!
Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.
Needham Keeps Their Hold Rating on Cresco Labs (CRLBF)
Cresco Labs Turns To Profit In Q4
Cannabis Comeback: 3 Stocks to Snag After the Bubble Burst
Cresco Labs Inc CRLBF
3 Cannabis Penny Stocks with Serious Potential to Make You a Millionaire
See More Headlines
Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/21/2023
Today
3/28/2024
Next Earnings (Estimated)
5/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:CRLBF
Fax
N/A
Employees
2,760
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.33
High Stock Price Target
$34.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+811.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-175,520,000.00
Pretax Margin
-19.06%

Debt

Sales & Book Value

Annual Sales
$770.89 million
Cash Flow
$0.06 per share
Book Value
$1.24 per share

Miscellaneous

Free Float
N/A
Market Cap
$770.73 million
Optionable
Not Optionable
Beta
2.24
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Thomas J. Manning (Age 68)
    Executive Chairman of the Board
    Comp: $800.05k
  • Mr. Charles Bachtell (Age 45)
    Co-Founder, CEO & Director
    Comp: $999.85k
  • Mr. Robert M. Sampson (Age 49)
    Co-Founder & Independent Director
  • Mr. Dennis M. Olis (Age 61)
    Chief Financial Officer
    Comp: $622.85k
  • Mr. Gregory Butler (Age 43)
    President & Chief Transformation Officer
  • Mr. Ty Gent (Age 65)
    Chief Operating Officer
  • Mr. Zach Marburger (Age 39)
    Chief Information Officer
  • Ms. Megan Kulick
    Senior Vice President of Investor Relations
  • Mr. John Schetz (Age 46)
    General Counsel
  • Mr. Jason Erkes (Age 53)
    Chief Communications Officer

CRLBF Stock Analysis - Frequently Asked Questions

Should I buy or sell Cresco Labs stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CRLBF shares.
View CRLBF analyst ratings
or view top-rated stocks.

What is Cresco Labs' stock price target for 2024?

3 Wall Street analysts have issued 1-year target prices for Cresco Labs' shares. Their CRLBF share price targets range from $2.00 to $34.00. On average, they anticipate the company's stock price to reach $20.33 in the next twelve months. This suggests a possible upside of 882.3% from the stock's current price.
View analysts price targets for CRLBF
or view top-rated stocks among Wall Street analysts.

How have CRLBF shares performed in 2024?

Cresco Labs' stock was trading at $1.3558 at the beginning of 2024. Since then, CRLBF stock has increased by 52.7% and is now trading at $2.07.
View the best growth stocks for 2024 here
.

Are investors shorting Cresco Labs?

Cresco Labs saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,759,900 shares, an increase of 28.7% from the February 29th total of 1,367,000 shares. Based on an average daily volume of 1,481,600 shares, the days-to-cover ratio is presently 1.2 days.
View Cresco Labs' Short Interest
.

When is Cresco Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 22nd 2024.
View our CRLBF earnings forecast
.

How were Cresco Labs' earnings last quarter?

Cresco Labs Inc. (OTCMKTS:CRLBF) announced its earnings results on Tuesday, March, 21st. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.01. The business had revenue of $199.58 million for the quarter, compared to the consensus estimate of $204.47 million. Cresco Labs had a negative net margin of 22.77% and a negative trailing twelve-month return on equity of 10.51%.

How do I buy shares of Cresco Labs?

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CRLBF) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners